---

COMPLETE LEARNING NOTE: ANTI-HYPERTENSIVE DRUGS

From Absolute Beginner to MBBS Examination Mastery

---

---

SECTION 1: BIG PICTURE OVERVIEW

"What Problem Does This Drug Class Solve?"

Start Here: Think Like a Plumber

---

Why Does This Matter So Much?

• It has NO symptoms in the early stages
• It silently damages the heart, kidneys, brain, and blood vessels for years
• By the time symptoms appear, serious organ damage has already occurred
• Strokes, heart attacks, heart failure, kidney failure, and blindness are its consequences

---

What Is the Drug Trying to Achieve?

1. The force on vessel walls decreases
2. The heart does not have to work as hard
3. Organs (brain, kidney, heart, retina) are protected from pressure damage
4. The risk of stroke, heart attack, and kidney failure falls dramatically

---

Where Can Drugs Intervene?

Blood Pressure = Cardiac Output × Peripheral Vascular Resistance
(BP = CO × PVR)

• Blood Pressure = how hard the blood pushes on vessel walls
• Cardiac Output (CO) = how much blood the heart pumps per minute
• Peripheral Vascular Resistance (PVR) = how narrow or wide the blood vessels are

• The heart pumps more (↑CO), OR
• The vessels get narrower (↑PVR), OR
• Both happen together

---

---

SECTION 2: BUILD THE FOUNDATION

Background Physiology and Pathophysiology

---

2.1 Normal Blood Pressure Regulation

• Systolic (120) = pressure when the heart contracts (pumps)
• Diastolic (80) = pressure when the heart relaxes (fills)
• Hypertension = persistently ≥ 130/80 mmHg (JNC/ACC/AHA 2017)
• Stage 1 HTN = 130-139/80-89 mmHg
• Stage 2 HTN = ≥ 140/90 mmHg
• Hypertensive urgency = severely elevated BP without organ damage
• Hypertensive emergency = severely elevated BP WITH acute organ damage

---

System 1: The RAAS (Renin-Angiotensin-Aldosterone System)

Low BP or Low Blood Volume detected by kidneys (juxtaglomerular cells)
                        ↓
Kidneys release RENIN (an enzyme)
                        ↓
Renin acts on ANGIOTENSINOGEN (made in liver)
                        ↓
Converts to ANGIOTENSIN I (inactive)
                        ↓
Angiotensin I reaches the lungs
                        ↓
ACE (Angiotensin-Converting Enzyme) converts it
                        ↓
ANGIOTENSIN II (very active!)
                        ↓
       Two powerful effects:
    ┌────────────────────────────────────┐
    │ 1. Directly constricts arteries     │ → ↑ PVR → ↑ BP
    │ 2. Stimulates adrenal cortex to    │
    │    release ALDOSTERONE             │
    └────────────────────────────────────┘
                        ↓
ALDOSTERONE acts on kidney collecting ducts
                        ↓
Retains Na+ (sodium) → Water follows Na+ → ↑ Blood Volume → ↑ CO → ↑ BP

• ACE inhibitors = block ACE (the enzyme that makes Angiotensin II)
• ARBs = block the Angiotensin II receptor (AT1 receptor)
• Aldosterone antagonists = block aldosterone's effect on kidneys
• Renin inhibitors = block renin at the very top of the cascade

---

System 2: The Sympathetic Nervous System (SNS)

Brain (hypothalamus) sends signals
            ↓
Sympathetic nerves release NOREPINEPHRINE (NE)
            ↓
NE acts on receptors in the heart and blood vessels:

α1 receptors (blood vessels) → Vasoconstriction → ↑ PVR → ↑ BP
β1 receptors (heart) → ↑ Heart rate + ↑ Contractility → ↑ CO → ↑ BP
β1 receptors (kidney JG cells) → ↑ Renin secretion → activates RAAS

• Beta-blockers = block β1 receptors (heart and kidney)
• Alpha-blockers = block α1 receptors (blood vessels)
• Central agents (clonidine, methyldopa) = reduce SNS output from the brain

---

System 3: Blood Volume (Fluid Balance)

High salt intake → more Na+ in blood → water follows → ↑ blood volume → ↑ BP
                                                         (Starling's law)

• Diuretics = force the kidney to excrete more Na+ and water → ↓ blood volume → ↓ BP

---

System 4: Vascular Tone (Vessel Wall Calcium)

• Angiotensin II signals
• Sympathetic (norepinephrine) signals
• Direct rise in intracellular calcium

Calcium enters L-type channel → Binds calmodulin → Activates myosin light-chain kinase
→ Actin-myosin interaction → Muscle contraction → Vasoconstriction → ↑ BP

• Calcium channel blockers = block L-type calcium channels → vessel relaxes → vasodilation → ↓ BP

---

2.2 Why Does Hypertension Develop? (Pathophysiology)

• Renal artery stenosis → reduced blood flow to kidney → kidney thinks BP is low → activates RAAS → ↑ BP
• Primary hyperaldosteronism (Conn's syndrome) → excess aldosterone → Na+ and water retention
• Pheochromocytoma → catecholamine-secreting tumor → massive SNS activation
• Cushing's syndrome → excess cortisol → Na+ retention, vascular effects
• Hypothyroidism / Hyperthyroidism
• Obstructive sleep apnea → chronic hypoxia → SNS activation

---

2.3 What Damage Does High Blood Pressure Cause?

HIGH BLOOD PRESSURE
        ↓
Acts on blood vessels everywhere in the body
        ↓
Three main vessel wall changes:
1. Endothelial dysfunction (inner lining damaged)
2. Medial hypertrophy (middle layer thickens)
3. Accelerated atherosclerosis (plaque formation)

---

---

SECTION 3: DRUG CLASS FRAMEWORK

The Six Major Classes of Anti-Hypertensive Drugs

---

CLASS 1: DIURETICS

1A. Thiazide Diuretics

Thiazide drug enters kidney tubule (DCT)
              ↓
Blocks Na+/Cl- cotransporter (NCC) on luminal membrane
              ↓
Less Na+ reabsorbed into blood
              ↓
Water stays in urine (follows Na+) → ↓ blood volume
              ↓
↓ Cardiac Output initially
              ↓
Long-term: vascular smooth muscle relaxes (mechanism incompletely understood)
              ↓
↓ Peripheral Vascular Resistance
              ↓
↓ Blood Pressure

• First-line for uncomplicated hypertension
• Particularly effective in: elderly patients, black patients, isolated systolic hypertension
• Heart failure (mild)
• Nephrolithiasis caused by hypercalciuria (thiazides reduce calcium excretion)
• Diabetes insipidus (nephrogenic)

• Gout (relative - worsens hyperuricemia)
• Hypokalemia
• Pregnancy
• Severe renal failure (GFR < 30 mL/min - thiazides lose effectiveness; use loop diuretics)

• Digoxin: hypokalemia → ↑ digoxin toxicity (dangerous!)
• NSAIDs: ↓ antihypertensive effect
• Lithium: ↑ lithium levels → toxicity
• ACE inhibitors: potentiates effect (good combination) but watch hypokalemia

---

1B. Loop Diuretics

Furosemide reaches loop of Henle
              ↓
Blocks NKCC2 transporter (luminal side)
              ↓
Na+, K+, Cl- all lost in urine
              ↓
Huge water loss → ↓ blood volume → ↓ BP
              ↓
Also dilates venous capacitance vessels rapidly (within minutes by PG-mediated effect)

• Furosemide (most widely used)
• Bumetanide (very potent, 1mg = 40mg furosemide)
• Torasemide (longer acting)
• Ethacrynic acid (only non-sulfonamide loop - used in sulfa allergy)

• Severe hypertension especially with heart failure
• Hypertension with renal failure (works even at low GFR unlike thiazides)
• Hypertensive emergencies (IV furosemide)
• Pulmonary edema (rapid IV)

• Thiazides: hypercalcemia (↓ Ca2+ excretion)
• Loop diuretics: hypocalcemia (↑ Ca2+ excretion)

---

1C. Potassium-Sparing Diuretics

Spironolactone enters collecting duct cell
              ↓
Competitively blocks aldosterone receptor
              ↓
Aldosterone cannot bind → cannot upregulate Na+/K+ ATPase
              ↓
Na+ and water excreted
K+ retained (not exchanged for Na+)
              ↓
↓ BP + K+ sparing effect

• Spironolactone: Non-selective aldosterone receptor blocker - also blocks androgen and progesterone receptors
• Eplerenone: Selective aldosterone antagonist (fewer hormonal side effects)

• Hypertension (as add-on, 4th agent)
• Heart failure (reduces mortality - RALES trial)
• Conn's syndrome (primary hyperaldosteronism) - drug of choice
• Resistant hypertension
• Liver cirrhosis with ascites

• Hyperkalemia (most dangerous - especially with ACE inhibitors, CKD, or K+ supplements)
• Gynecomastia in men (blocks androgen receptors - feminizing effect)
• Menstrual irregularities in women
• Eplerenone avoids these hormonal effects

• Not as powerful as aldosterone antagonists
• Used to prevent thiazide-induced hypokalemia
• Amiloride used in Liddle syndrome (overactive ENaC)

---

CLASS 2: BETA-ADRENERGIC BLOCKERS (BETA-BLOCKERS)

What Are Beta Receptors?

• β1 receptors (mainly heart and kidney):
  • In heart → ↑ heart rate, ↑ force of contraction
  • In kidney → ↑ renin release → activates RAAS
• β2 receptors (mainly lungs and blood vessels):
  • In lungs → bronchodilation
  • In vessels → vasodilation

Beta-blocker occupies β1 receptor
              ↓
Heart:
  → ↓ Heart rate (negative chronotropy)
  → ↓ Contractility (negative inotropy)
  → ↓ Cardiac Output → ↓ BP

Kidney:
  → ↓ Renin secretion → ↓ Angiotensin II → ↓ Aldosterone
  → ↓ Vasoconstriction + ↓ Na+ retention → ↓ BP

Brain (central effect):
  → ↓ Central sympathetic outflow (some agents)

Classification of Beta-Blockers

Drug Properties at a Glance

Clinical Uses of Beta-Blockers in Hypertension

• Post-myocardial infarction (reduce reinfarction and death)
• Heart failure with reduced EF (HFrEF) - carvedilol, bisoprolol, metoprolol succinate
• Hypertension with angina pectoris
• Hypertension with supraventricular tachyarrhythmias
• Aortic dissection (esmolol + nitroprusside)
• Hypertension in pheochromocytoma (only AFTER alpha-blockade is established)
• Hypertension in pregnancy: labetalol

Adverse Effects - Linked to Physiology

Contraindications

• Asthma / COPD (severe) - β2 blockade causes bronchospasm
• Cardiogenic shock
• Severe bradycardia / high-degree heart block (without pacemaker)
• Acute decompensated heart failure (NOT the time to start)
• Prinzmetal's (variant) angina - vasospasm can worsen with non-selective agents
• Pheochromocytoma without prior alpha-blockade (paradoxical hypertensive crisis!)
• Diabetes mellitus (relative - masks hypoglycemia, worsens glucose intolerance)
• Peripheral arterial disease (relative - worsens claudication)
• Raynaud's phenomenon

---

CLASS 3: CALCIUM CHANNEL BLOCKERS (CCBs)

The Simple Picture

Types of Calcium Channels

Classification of CCBs

Mechanism (Step by Step)

Amlodipine binds to L-type Ca2+ channel on vascular smooth muscle
              ↓
Channel blocked → Ca2+ cannot enter the cell
              ↓
↓ Intracellular Ca2+ → myosin light-chain kinase not activated
              ↓
Smooth muscle RELAXES → vasodilation
              ↓
↓ Peripheral Vascular Resistance → ↓ BP

Verapamil/Diltiazem block L-type Ca2+ channels in BOTH:
  1. Heart muscle → ↓ contractility (verapamil > diltiazem)
  2. SA node → ↓ heart rate
  3. AV node → ↓ conduction (useful in SVT)
  4. Blood vessels → vasodilation (↓ PVR)

Drug Details

Clinical Uses

Adverse Effects

Critical Drug Interactions

Both slow the heart and AV node:
Verapamil (blocks Ca2+ in AV node) + Beta-blocker (blocks β1 in AV node)
           ↓
Additive AV block → Complete heart block → Cardiac arrest

Contraindications

---

CLASS 4: ACE INHIBITORS (ACEIs)

The Simple Picture

Mechanism (Step by Step)

Normal RAAS:
Angiotensin I → [ACE enzyme] → Angiotensin II → ↑ BP

With ACE Inhibitor:
Angiotensin I → [ACE enzyme BLOCKED] → ↓ Angiotensin II
              ↓
Result 1: ↓ Vasoconstriction → ↓ PVR → ↓ BP
Result 2: ↓ Aldosterone → ↓ Na+/water retention → ↓ blood volume → ↓ BP
Result 3: ↑ Bradykinin (ACE normally degrades bradykinin; now it accumulates)
          Bradykinin → vasodilation, anti-inflammatory, but also → COUGH and ANGIOEDEMA
Result 4: ↓ Sympathetic activation (indirect)
Result 5: ↓ Efferent arteriolar tone in kidney → ↓ glomerular pressure → renoprotective

Prodrugs vs Active Drugs

Clinical Uses

• Hypertension with diabetes mellitus (reduces diabetic nephropathy even if BP is normal)
• Hypertension with CKD (reduces proteinuria, slows progression)
• Heart failure (reduces preload + afterload + prevents remodeling)
• Post-MI (reduces ventricular remodeling, mortality)
• LV dysfunction (asymptomatic - slows progression to failure)
• Proteinuria (any cause - reduces glomerular pressure)

Adverse Effects - Linked to Physiology

Contraindications

• Pregnancy (absolute - causes fetal renal agenesis, skull hypoplasia, limb contractures = "ACE inhibitor fetopathy")
• Bilateral renal artery stenosis (or unilateral in a single kidney)
• Hyperkalemia (K+ > 5.5 mEq/L)
• History of angioedema from ACEIs
• Avoid in combination with ARB in CKD (↑ risk of hyperkalemia, AKI - ONTARGET trial)

Why ACEI-Induced Cough Does Not Occur with ARBs

ACE inhibitor → blocks ACE → ↑↑ Bradykinin → COUGH and ANGIOEDEMA

ARB → blocks AT1 receptor → does NOT affect ACE → bradykinin levels NORMAL → NO COUGH
(ARBs have rare angioedema, but much less - via a different bradykinin-independent mechanism)

---

CLASS 5: ANGIOTENSIN RECEPTOR BLOCKERS (ARBs)

The Simple Picture

Mechanism

Angiotensin II is produced (by various pathways)
              ↓
ARB occupies AT1 receptor (competitive antagonist)
              ↓
Angiotensin II cannot bind to AT1 receptor
              ↓
No vasoconstriction, no aldosterone release
              ↓
↓ PVR → ↓ BP + ↓ Na+ retention → ↓ blood volume → ↓ BP

Note: AT2 receptor is NOT blocked by ARBs
      Unblocked AT2 + more Angiotensin II (due to blocked AT1) 
      → AT2 activated → vasodilation, anti-fibrotic, anti-proliferative
      (This may provide additional cardiovascular protection)

Drugs and Properties

Clinical Uses

• Preferred when ACE inhibitor causes intolerable cough
• Diabetic nephropathy - especially irbesartan, losartan
• Hypertension in patients with LVH (LIFE trial: losartan vs atenolol - losartan superior for stroke prevention)
• Heart failure - valsartan, candesartan (when ACEI not tolerated)

Adverse Effects

• NO COUGH (no bradykinin accumulation)
• Angioedema much rarer (<0.3% vs 0.5% with ACEIs)
• Hyperkalemia - still occurs (same mechanism)
• Teratogenic - same contraindication as ACEIs
• First-dose hypotension - similar

Key Differences: ACEI vs ARB

---

CLASS 6: OTHER ANTI-HYPERTENSIVE AGENTS

6A. Direct Renin Inhibitors

• Blocks renin at the VERY TOP of the RAAS cascade
• Renin cannot cleave angiotensinogen → ↓ Angiotensin I and II and aldosterone
• Oral; once daily; long half-life
• Used in hypertension (monotherapy)
• Adverse effects: Diarrhea, hyperkalemia, renal impairment
• Contraindicated: With ACEIs or ARBs in diabetics or those with CKD (increased adverse events - ALTITUDE trial)
• Teratogenic

---

6B. Alpha-1 Adrenergic Blockers

Alpha-1 blockers → block α1 receptors on vascular smooth muscle
              ↓
No sympathetic vasoconstriction
              ↓
Vasodilation of arteries AND veins
              ↓
↓ PVR → ↓ BP + ↓ venous return → ↓ CO

• Hypertension + benign prostatic hyperplasia (BPH) - α1 blockade relaxes bladder neck and prostate smooth muscle → helps urine flow (terazosin, doxazosin very useful here)
• Pheochromocytoma - phenoxybenzamine (non-selective, irreversible) or phentolamine (non-selective, competitive, IV) used FIRST, then beta-blockade added

---

6C. Centrally Acting Sympatholytics

These drugs act IN THE BRAIN (brainstem)
              ↓
They ACTIVATE α2 receptors in the vasomotor center (nucleus tractus solitarius)
              ↓
α2 activation is an INHIBITORY signal in the sympathetic pathway
              ↓
↓ Norepinephrine release from sympathetic nerves
              ↓
↓ Heart rate, ↓ contractility, ↓ vasoconstriction
              ↓
↓ BP

• Available oral AND as transdermal patch (useful in non-compliant patients)
• Also used for: opioid/alcohol withdrawal, ADHD (kids), menopausal flushing, pain management
• Critical: Rebound hypertension on sudden withdrawal (especially at high doses; tachycardia + BP crisis; always taper!)
• Adverse effects: Sedation, dry mouth, constipation, depression, sexual dysfunction
• Drug interactions: Tricyclic antidepressants (TCAs) block clonidine's effect → loss of BP control

• Prodrug → converted to alpha-methylnorepinephrine (a false neurotransmitter) → activates central α2 receptors → ↓ SNS output
• Drug of choice in hypertension during pregnancy (long safety record)
• Adverse effects:
  • Sedation, fatigue
  • Positive direct Coombs test (>20% of patients)
  • Hemolytic anemia (rare, 0.5-1%)
  • Drug fever
  • Hepatotoxicity (rare)
  • Hyperprolactinemia → galactorrhea

---

6D. Direct Vasodilators

Hydralazine → opens K+ channels in vascular smooth muscle (mechanism not fully known)
              ↓
Hyperpolarization of smooth muscle cell → Ca2+ channels close
              ↓
Smooth muscle relaxes → Arteriolar dilation (minimal venodilation)
              ↓
↓ PVR → ↓ BP

• Reflex tachycardia
• Na+ and water retention (counteracts BP lowering)
• This is why hydralazine is rarely used as monotherapy

• Hypertension in pregnancy (IV hydralazine - safe for fetus; widely used in eclampsia/severe preeclampsia)
• Severe resistant hypertension (combined therapy)
• Heart failure (Hydralazine + isosorbide dinitrate = "BiDil" combination; effective in black patients with HFrEF when ACEI/ARB not tolerated)

• Reflex tachycardia
• Fluid retention
• Drug-induced lupus erythematosus (SLE) - most important! Especially at doses > 200 mg/day; slow acetylators more susceptible (NAT2 polymorphism); presents with fever, arthralgia, ANA positive
• Headache, flushing
• Peripheral neuropathy (pyridoxine deficiency - give B6)

• Opens K+ channels → vasodilation
• More potent than hydralazine; used for severe/resistant hypertension
• Must use with beta-blocker and loop diuretic
• Adverse effects: Hirsutism/hypertrichosis (hair growth everywhere - basis of topical Rogaine for baldness), fluid retention, pericardial effusion
• Topical form: Treatment of male-pattern baldness

---

6E. Drugs for Hypertensive Emergencies

• Mechanism: Spontaneously releases NO → stimulates guanylyl cyclase → ↑ cGMP → smooth muscle relaxation → profound vasodilation of arteries AND veins
• Advantages: Fastest-acting; easily titratable; works on all vessel types
• Cyanide toxicity (most important adverse effect): SNP is metabolized to cyanide; accumulated cyanide inhibits cytochrome oxidase → tissue hypoxia; co-administer sodium thiosulfate to prevent
• Thiocyanate toxicity: Especially with renal failure
• Reflex tachycardia: Combine with beta-blocker
• Must be protected from light (degrades rapidly)
• Monitor: BP continuously via arterial line

---

---

SECTION 4: TEACH USING ANALOGIES

The Master Analogy Library

Water Tower City Analogy

• Too much water in the system (excess blood volume) → pressure goes up → like filling the tower too full → DIURETICS are like drainage taps - they let some water out
• Pipes that are too narrow (vasoconstriction) → pressure goes up at same flow rate → CCBs and ACEIs/ARBs are like calling a plumber to widen the pipes
• The pump works too hard (high cardiac output/rate) → pressure goes up → Beta-blockers are like slowing the pump motor
• The governor control system (RAAS/SNS) is set too high → keeps tightening pipes and filling the tower → ACEIs/ARBs and clonidine/methyldopa are like resetting the governor to a lower setting

---

Drug-by-Drug Vivid Analogies

---

---

SECTION 5: STEP-BY-STEP CLINICAL REASONING

Case-Based Clinical Thinking

---

Case 1: A 45-Year-Old with Uncomplicated Hypertension

• Thiazide diuretic
• CCB (amlodipine)
• ACEI or ARB

• Black race → Thiazide or CCB preferred (ACEIs/ARBs less effective in blacks with low-renin HTN)
• Cost → Thiazide cheapest
• Side-effect tolerance → ACEI cough common; CCB edema common

• ACEI + CCB (best combination - complementary mechanisms, reduced edema)
• ACEI + Thiazide (very effective)
• CCB + Thiazide (effective)

---

Case 2: 58-Year-Old Diabetic with Microalbuminuria

---

Case 3: 65-Year-Old Post-MI with HTN

---

Case 4: Pregnant Woman with Hypertension

• ACE inhibitors → fetal renal defects (fetopathy)
• ARBs → same mechanism
• Aliskiren → teratogen
• Thiazides → fetal thrombocytopenia, neonatal hypoglycemia (use with caution)

• Methyldopa - drug of choice for chronic HTN in pregnancy (decades of safety data)
• Labetalol - very commonly used, safe
• Nifedipine - safe for chronic use
• Hydralazine (IV) - for hypertensive emergencies in pregnancy/eclampsia

• IV labetalol
• IV hydralazine
• IV nicardipine
• Oral nifedipine
• Magnesium sulfate (for seizure prevention - not antihypertensive)

---

Case 5: Hypertensive Emergency

• Reducing too fast → cerebral ischemia (brain adapted to high pressure; rapid drop causes ischemia in watershed zones)

• Nicardipine (IV infusion) - excellent for most emergencies
• Labetalol (IV) - especially if aortic dissection or pregnancy
• Sodium nitroprusside (IV) - most powerful; ICU monitoring required

---

Case 6: Pheochromocytoma

• β2 vasodilation is blocked
• α1 vasoconstriction is UNOPPOSED
• Result: Paradoxical severe hypertension and hypertensive crisis!

1. Phenoxybenzamine (irreversible non-selective alpha blocker) for 10-14 days pre-op
2. Then add propranolol (beta-blocker) if tachycardia persists
3. Volume replacement (patients are chronically vasoconstricted → volume depleted)
4. Surgical resection

---

---

SECTION 6: MEMORY TOOLS

Mnemonics, Tables, and Memory Tricks

---

Mnemonic 1: JNC8 First-Line Drugs = "ABCD"

---

Mnemonic 2: Thiazide Side Effects = "GLUC-HK"

---

Mnemonic 3: ACE Inhibitor Adverse Effects = "CAPTOPRIL"

---

Mnemonic 4: Drugs Preferred in Pregnancy = "MANL"

---

Mnemonic 5: Beta-Blocker Contraindications = "ABCDE"

---

Mnemonic 6: Compelling Indications - "Which Drug for Which Disease?"

---

Drug Comparison Table: Complete Overview

---

---

SECTION 7: EXAMINER'S CORNER

What Examiners Test Most

---

Most Tested Facts

1. ACE inhibitors cause cough - why? ↑ Bradykinin accumulation in lungs
2. ACE inhibitors are teratogenic - fetal renal agenesis, ABSOLUTELY contraindicated in pregnancy
3. Drug of choice in pregnancy HTN: Methyldopa (chronic), Labetalol, Hydralazine (acute)
4. Chlorthalidone > HCTZ - better antihypertensive efficacy due to longer half-life
5. Spironolactone causes gynecomastia in males due to anti-androgen effect
6. Verapamil + beta-blocker = complete heart block - DO NOT combine
7. Nimodipine is used for cerebral vasospasm after SAH - not general hypertension
8. Short-acting nifedipine is CONTRAINDICATED in acute MI (reflex tachycardia increases myocardial oxygen demand)
9. Give alpha-blocker BEFORE beta-blocker in pheochromocytoma - reverse order causes HTN crisis
10. Hydralazine → drug-induced lupus (ANA positive, slow acetylators at risk)

---

Most Likely Essay Questions

1. "Classify anti-hypertensive drugs. Describe the mechanism of action of ACE inhibitors and their clinical uses."
2. "Discuss the pharmacological management of hypertensive emergencies."
3. "What are compelling indications for each class of anti-hypertensive drug? Explain with mechanisms."
4. "Describe the RAAS. How do ACE inhibitors and ARBs differ in their site and mechanism of action?"
5. "A patient develops cough on enalapril. What is the mechanism and what alternative drug would you prescribe?"
6. "Describe the pharmacology of calcium channel blockers. How do dihydropyridines differ from non-dihydropyridines?"

---

Most Likely Short Notes

• Mechanism of captopril
• Drug-induced lupus (hydralazine)
• Cough with ACE inhibitors
• First-dose effect of prazosin
• Thiazide diuretics in hypertension
• Spironolactone - mechanism and uses
• Labetalol in hypertensive emergencies
• Sodium nitroprusside
• Clonidine withdrawal
• Methyldopa in pregnancy

---

Most Likely Viva Questions

• "What is the mechanism of ACE inhibitor-induced cough? What receptor is involved?"
• "Why are ACE inhibitors preferred in diabetic nephropathy?"
• "Why can we not give beta-blockers first in pheochromocytoma?"
• "What is the difference between verapamil and amlodipine?"
• "Why is bilateral renal artery stenosis a contraindication for ACE inhibitors?"
• "What is the mechanism of hydralazine-induced lupus?"
• "Why is clonidine not stopped suddenly?"
• "What is the antidote for cyanide toxicity from nitroprusside?"

---

Most Likely MCQs and Common Traps

---

Common Student Errors to Avoid

1. Confusing thiazide and loop diuretic calcium effects (thiazide RETAINS calcium; loop LOSES calcium)
2. Forgetting that ARBs are also teratogenic (same as ACEIs)
3. Thinking non-selective beta-blockers are safe in asthma (they are NOT)
4. Forgetting that spironolactone RETAINS potassium (students think all diuretics lose K+)
5. Not knowing that all ACEIs except lisinopril are prodrugs
6. Confusing the mechanism of cough (bradykinin) with direct ACE effect
7. Not knowing the alpha-first rule in pheochromocytoma
8. Calling verapamil safe with beta-blockers (it is dangerous)
9. Forgetting that chlorthalidone is superior to HCTZ (commonly tested as HCTZ being better)
10. Not knowing methyldopa causes a positive Coombs test (most commonly tested adverse effect)

---

---

SECTION 9: HIGH-YIELD REVISION SHEET

One-Page Summary - Anti-Hypertensives

---

THE FIVE MECHANISMS

1. DIURETICS → ↓ blood volume → ↓ CO → ↓ BP
2. BETA-BLOCKERS → ↓ HR + contractility + renin → ↓ CO → ↓ BP
3. CCBs → vasodilation → ↓ PVR → ↓ BP (DHPs) + ↓ HR (non-DHPs)
4. ACEIs / ARBs → ↓ Angiotensin II effects → ↓ PVR + ↓ Na+ retention → ↓ BP
5. SYMPATHOLYTICS → ↓ SNS output → ↓ CO + ↓ PVR → ↓ BP

---

MUST-KNOW DRUGS

---

MUST-KNOW TOXICITIES

---

MUST-KNOW CLINICAL USES

---

EXAM EMERGENCY FACTS (Last-Minute Recall)

1. ACE inhibitor cough = BRADYKININ
2. ACEIs and ARBs = TERATOGENIC
3. Methyldopa = drug of choice in PREGNANCY HTN
4. Thiazides RAISE Ca2+; Loop diuretics LOWER Ca2+
5. Spironolactone causes GYNECOMASTIA (not hypokalemia - it prevents hypokalemia!)
6. Verapamil + Beta-blocker = HEART BLOCK (NEVER combine)
7. Nimodipine = CEREBRAL vasospasm after SAH
8. Phenoxybenzamine FIRST in pheochromocytoma (alpha before beta!)
9. Clonidine = rebound HTN if stopped SUDDENLY
10. Hydralazine = drug-induced LUPUS (ANA+, slow acetylators)
11. Nitroprusside → CYANIDE toxicity (treat with sodium thiosulfate)
12. Max dose thiazide = 25mg HCTZ or chlorthalidone (higher doses don't add antihypertensive benefit, add toxicity)

---

---

SECTION 10: SELF-ASSESSMENT

10 Short-Answer Questions with Full Explanations

---

---

---

---

---

• Arthralgia, myalgia, fever, serositis (pleuritis, pericarditis)
• Positive ANA (antinuclear antibody)
• Anti-histone antibodies (hallmark of drug-induced lupus vs. idiopathic SLE)
• Renal and CNS involvement are RARE (unlike idiopathic SLE)
• Resolves on stopping the drug

---

• Reassure that the edema is not dangerous
• Consider reducing amlodipine dose
• Add an ACE inhibitor or ARB - these agents dilate the postcapillary venule (via reduced angiotensin II), which reduces capillary hydrostatic pressure and counteracts the edema
• This is the rationale for the ACE inhibitor + CCB combination being particularly well-tolerated

---

• Severe bradycardia
• High-degree AV block (2nd or 3rd degree heart block)
• Complete cardiac standstill

---

---

• ACE inhibitors (e.g., enalapril, captopril): Cause fetal renal dysgenesis, oligohydramnios, skull hypoplasia, limb contractures, death. The fetal kidney depends on angiotensin II for development, particularly in the 2nd and 3rd trimesters.
• ARBs (e.g., losartan): Same mechanism and same teratogenic effects as ACEIs.
• Aliskiren: Also teratogenic.

---

1. Cyanide toxicity (most important): SNP contains five cyanide groups. As it metabolizes, cyanide is released. Cyanide inhibits cytochrome c oxidase (Complex IV of mitochondrial electron transport chain) → cells cannot utilize oxygen → lactic acidosis, confusion, seizures. Occurs with prolonged infusion or high doses, especially with hepatic or renal impairment.
2. Thiocyanate toxicity: Cyanide is converted to thiocyanate in the liver (requires thiosulfate and rhodanese). Thiocyanate can accumulate especially in renal failure → blurred vision, tinnitus, delirium.
3. Reflex tachycardia: Rapid BP drop → baroreceptor-mediated SNS activation. Combine with a beta-blocker (especially in aortic dissection).
4. Light sensitivity: SNP degrades rapidly on exposure to light; must be protected with dark wrapping.

• Sodium thiosulfate (co-administer with SNP infusion in high-risk situations): thiosulfate donates sulfur to rhodanese enzyme, converting cyanide to thiocyanate
• Hydroxocobalamin (Cyanokit): binds cyanide to form cyanocobalamin (non-toxic) - used for acute cyanide poisoning
• Dicobalt edetate (alternative in some countries)

---

---